RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

Send Inquiry

Request To Call Back

RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

Name: RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML
Brand: OCEAN PHARMACEUTICAL
Price: 32675.58 INR
Availability: InStock

Price 32675.58 INR/ Pack

Get a Price/Quote

MOQ : 100 Packs

RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML Specification

Salt Composition
Rituximab 10mg/ml

Indication
Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis

Dosage Form
Concentrate for Solution for Infusion

Enzyme Types
Not applicable (Monoclonal antibody, not an enzyme)

Feature
Ready-to-dilute sterile concentrate; preservative free; for hospital/institutional use

Ingredients
Rituximab, Polysorbate 80, Sodium Chloride, Sodium Citrate, Citric Acid, Water for Injection

Application
Intravenous infusion for cancer and autoimmune disorders

Ph Level
6.5 - 7.0 (approximate)

Temperature Needed For Fermentation
Not applicable (biotechnological production, not classical fermentation)

Physical Color/Texture
Clear to slightly opalescent, colorless to pale yellow liquid

Storage Instructions
AS PER INSTRUCTIONS

Shelf Life
24 months (Unopened vial)

Administration Route
Intravenous only

Caution
For use by registered medical practitioners or hospitals only

Manufacturing Method
Produced by recombinant DNA technology

Prescription Status
Rx (Prescription only)

Packaging
Glass vial with rubber stopper

Strength
500mg/50ml or 100mg/10ml

Dilution Instructions
Must be diluted with 0.9% Sodium Chloride prior to administration

RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML Trade Information

Minimum Order Quantity
100 Packs

FOB Port
AHEMDABAD, MUNDRA & MUMBAI

Supply Ability
1000 Packs Per Month

Delivery Time
2 Week

Packaging Details
FOR SINGLE DOSE VIAL

Certifications
AS PER AVAILABILITY

About RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

PRODUCT NAME:iRITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/M

GENERIC NAME:iRITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

MANUFACTURER: OCEAN

PACKING: SINGLE DOSE VIAL

USES:iRituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells.

Some brands of rituximab are also used to treat rheumatoid arthritis and can decrease joint pain and swelling. This drug is also used to treat certain types of blood vessel disease (such as granulomatosis with polyangiitis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions.

Advanced Monoclonal Antibody Therapy

Rituximab delivers targeted treatment for certain cancers and autoimmune disorders. By targeting CD20-positive cells, it can help reduce disease activity and improve patient outcomes. The product is ideal for use in hospital and institutional settings under careful supervision.

Strict Quality Standards and Ready-to-Use Packaging

Manufactured in India using modern recombinant DNA technology, each vial is quality-tested and sterile. It is preservative-free and comes ready for dilution. Practitioners can expect clear to slightly opalescent, colorless to pale yellow liquid with a pH close to physiological values.

Comprehensive Application and Preparation Guidelines

Rituximab concentrate must be diluted with 0.9% Sodium Chloride before use, guaranteeing safety and correct dosing. Only registered medical practitioners should administer this intravenously, following prescription and dosage guidelines specific to each indication.

FAQ's of RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML:

Q: How should Rituximab Concentrate for Solution for Infusion 10mg/ml be prepared and administered?

A: Rituximab must be diluted with 0.9% Sodium Chloride before intravenous infusion. The concentrate is not to be administered undiluted and should be handled only by healthcare professionals following aseptic techniques within hospital or institutional environments.

Q: What conditions are treated with Rituximab Concentrate, and who benefits from it?

A: Rituximab is indicated for treatment of Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis. Patients with these cancers or autoimmune disorders may benefit from its targeted therapeutic approach.

Q: When should Rituximab be administered, and what are the dosage guidelines?

A: The timing and dosage for Rituximab administration depend on the specific condition being addressed and are determined by the prescribing physician. All dosage regimens must strictly follow medical instructions provided for the patient's diagnosis.

Q: Where should Rituximab vials be stored prior to use?

A: Unopened Rituximab vials should be stored according to the instructions provided, typically in a controlled environment as specified in the product's storage guidelines, ensuring stability within its 24-month shelf life.

Q: What is the physical appearance of Rituximab Concentrate, and how do you identify it?

A: The concentrate is a clear to slightly opalescent, colorless to pale yellow liquid. Each vial is packaged with a glass container and rubber stopper, ensuring sterility and authenticity.

Q: What are the main benefits of using Rituximab in intravenous infusions?

A: Rituximab provides targeted immune modulation with established efficacy in cancer and autoimmune therapy. Its ready-to-dilute format and absence of preservatives promote safety for hospital or institutional administration, optimizing patient care.

Tell us about your requirement